Optical coherence tomography in STEMI with bioresorbable scaffold: Possible cause of coronary flow impairment? A sub-study from the Prague 19 trial
Heart and Vessels May 24, 2018
Loffi M, et al. - Researchers searched for the influence of the Optical Coherence Tomography (OCT) on the coronary flow in ST-elevation myocardial infarction (STEMI) after bioresorbable scaffold implantation. From the Prague 19 trial, they selected 54 patients with OCT performed at the end of procedure and evaluated coronary flow as TIMI frame count (TFC) before and just after OCT. Outcomes suggested the feasibility of OCT at the end of primary percutaneous coronary intervention with bioresorbable scaffold. However, it appeared to have a correlation with flow deterioration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries